Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosis.

[1]  K. Seuwen,et al.  ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans. , 2011, Bone.

[2]  Bo Wang,et al.  Determination of Absolute Configuration of Chiral Molecules Using Vibrational Optical Activity: A Review , 2011, Applied spectroscopy.

[3]  L. Widler.  Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis. , 2011, Future medicinal chemistry.

[4]  K. Fukuda,et al.  Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone. , 2011, ACS medicinal chemistry letters.

[5]  J. Bauman,et al.  Metabolism-guided design of short-acting calcium-sensing receptor antagonists. , 2010, ACS medicinal chemistry letters.

[6]  P. Marie.  The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. , 2010, Bone.

[7]  E. Altmann,et al.  1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: a novel series of potent calcium-sensing receptor antagonists. , 2010, Journal of medicinal chemistry.

[8]  E. Brown,et al.  Biochemistry and biology of the extracellular calcium-sensing receptor , 2009 .

[9]  M. Rubin,et al.  The use of parathyroid hormone in the treatment of osteoporosis , 2007, Reviews in Endocrine and Metabolic Disorders.

[10]  J. Compston.  Recombinant Parathyroid Hormone in the Management of Osteoporosis , 2005, Calcified Tissue International.

[11]  L. Gelbert,et al.  Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray , 2005, Journal of cellular biochemistry.

[12]  E. Brown,et al.  THE CALCIUM-SENSING RECEPTOR IN NORMAL PHYSIOLOGY AND PATHOPHYSIOLOGY: A Review , 2005, Critical reviews in clinical laboratory sciences.

[13]  B. R. Smith,et al.  Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. , 2000, The Journal of clinical investigation.

[14]  R. Lindsay,et al.  The Anabolic Effects of Parathyroid Hormone , 2002, Osteoporosis International.

[15]  M. Faul,et al.  Bis(oxazolines) as chiral ligands in metal-catalyzed asymmetric reactions. Catalytic, asymmetric cyclopropanation of olefins , 1991 .